Viewing Study NCT02820961


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2025-12-28 @ 5:10 PM
Study NCT ID: NCT02820961
Status: COMPLETED
Last Update Posted: 2021-12-15
First Post: 2016-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
Sponsor: Syndax Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module